Back

Low levels of irisin predicted worsening kidney function in dapagliflozin-treated patients with chronic heart failure and concomitant type 2 diabetes mellitus

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - biomarkers 3 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Alexander E Berezin

Paracelsus Private Medical University, Salzburg (Austria)

2 More presentations in this session

Presentation thumbnail
Increased CD4+ T lymphocyte count is associated with mortality in patients with heart failure and type 2 cardiorenal syndrome
Doctor A. Bechlioulis (Ioannina, GR)
Abstract Slides Video
Presentation thumbnail
Albuminuria predicts the progression of diastolic dysfunction in patients at risk for cardiovascular disease
Doctor K. Min (Nishinomiya, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - biomarkers 3

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Predictors of kidney-related outcomes in chronic heart failure patients with concomitant type 2 diabetes mellitus treated with dapagliflozin
thumbnail
Congress Presentation
Cardiovascular diseases and type 2 diabetes mellitus: high heart failure risk and low rate contraindications to SGLT2i
thumbnail
Congress Presentation
Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources